| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 827* | 2021 |
| Anti-commensal IgG drives intestinal inflammation and type 17 immunity in ulcerative colitis T Castro-Dopico, TW Dennison, JR Ferdinand, RJ Mathews, A Fleming, ... Immunity 50 (4), 1099-1114. e10, 2019 | 177 | 2019 |
| Anthelmintics for people with neurocysticercosis EJM Monk, K Abba, LN Ranganathan Cochrane Database of Systematic Reviews, 2021 | 134 | 2021 |
| Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study A Atti, F Insalata, EJ Carr, AD Otter, J Castillo-Olivares, M Wu, R Harvey, ... Journal of Infection 85 (5), 545-556, 2022 | 24 | 2022 |
| Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model D Pople, EJM Monk, S Evans, S Foulkes, J Islam, E Wellington, A Atti, ... bmj 378, 2022 | 21 | 2022 |
| Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis CJ Calderwood, JP Wilson, KL Fielding, RC Harris, AS Karat, ... PLoS medicine 18 (4), e1003566, 2021 | 18 | 2021 |
| Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all-cause hospital admission EJM Monk, C Harris, R Döffinger, G Hayes, DW Denning, C Kosmidis Thorax 75 (6), 513-516, 2020 | 16 | 2020 |
| Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national … L Mndala, EJM Monk, D Phiri, J Riches, R Makuluni, L Gadama, ... The Lancet Global Health 10 (11), e1623-e1631, 2022 | 14 | 2022 |
| Factors affecting tuberculosis health message recall 2 years after active case finding in Blantyre, Malawi EJM Monk, M Kumwenda, M Nliwasa, J Mpunga, EL Corbett The International Journal of Tuberculosis and Lung Disease 22 (9), 1007-1015, 2018 | 10 | 2018 |
| Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study A Atti, M Ferrari, J Castillo-Olivares, EJM Monk, R Gopal, M Patel, ... The Journal of Infection 84 (2), 248, 2022 | 7 | 2022 |
| Incidence of candidaemia in prolonged venovenous extracorporeal membrane oxygenation EJM Monk, R Rautemaa-Richardson, T Felton, A Montalti, M Parkes, ... Journal of Hospital Infection 119, 49-53, 2022 | 7 | 2022 |
| Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022 S Foulkes, EJM Monk, D Sparkes, N Hettiarachchi, ID Milligan, K Munro, ... Emerging infectious diseases 29 (1), 184, 2023 | 4 | 2023 |
| Determination of true patient origin through motorcycle mapping: design and implementation of a community-defined geographic infrastructure surveillance tool in rural Sierra Leone EJM Monk, KP Yee, R Allan, IB Gayton Transactions of The Royal Society of Tropical Medicine and Hygiene 113 (9 …, 2019 | 2 | 2019 |
| Antimicrobial resistance in bacterial wound, skin, soft tissue and surgical site infections in Central, Eastern, Southern and Western Africa: A systematic review and meta-analysis EJM Monk, TPW Jones, F Bongomin, W Kibone, Y Nsubuga, N Ssewante, ... PLOS Global Public Health 4 (4), e0003077, 2024 | 1 | 2024 |
| Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi L Mndala, C Chapuma, J Riches, L Gadama, F Kachale, R Bilesi, ... Emerging infectious diseases 29 (10), 2023 | 1 | 2023 |
| Cyclone Freddy and its Impact on Women's Health: Data from a National Maternal Surveillance Platform in Malawi HH Twabi, J Jafali, L Mndala, J Riches, EJM Monk, D Phiri, R Makuluni, ... | | |
